NuPathe, Inc. (PATH) Posts Narrower than Expected Loss of 38c/Share

NuPathe, Inc. (NASDAQ: PATH) reported Q4 EPS of ($0.38), $0.12 better than the analyst estimate of ($0.50).

For earnings history and earnings-related data on NuPathe, Inc. (PATH) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c